StockClub

SYRS

SYRSSyros Pharmaceuticals, Inc.$ --
Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals, Inc.

SYRS

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2024FY2024 Q3
Revenue
0M USD
YoY -100.0%
Operating Income
-26M USD
YoY +24.4%
Net Income
-6M USD
YoY +84.1%
EPS
-0.16$
YoY +88.8%

Revenue

$0
FY2022 Q4$10.2M
$10.2M
Q4
FY2023 Q1$3M
$3M
Q1
FY2023 Q2$5.8M
$5.8M
Q2
FY2023 Q3$9.5M
$9.5M
Q3
FY2023 Q4$9.9M
$9.9M
Q4
FY2024 Q1$0
$0
Q1
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
Actual
$-9.5M (-100.0%)

Net Income

$-33.4M
FY2022 Q4$-52.3M
$-52.3M
Q4
FY2023 Q1$-14.9M
$-14.9M
Q1
FY2023 Q2$-51.2M
$-51.2M
Q2
FY2023 Q3$-91.3M
$-91.3M
Q3
FY2023 Q4$-155.7M
$-155.7M
Q4
FY2024 Q1$-3.7M
$-3.7M
Q1
FY2024 Q2$-27M
$-27M
Q2
FY2024 Q3$-33.4M
$-33.4M
Q3
Actual
+$57.9M (+63.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2018BEAT
Actual:$2M
Est:$1.6M
FY2018BEAT
$2M
FY2019MISS
Actual:$2M
Est:$2.2M
FY2019MISS
$2M
FY2020BEAT
Actual:$15.1M
Est:$12.1M
FY2020BEAT
$15.1M
FY2021BEAT
Actual:$23.5M
Est:$20.5M
FY2021BEAT
$23.5M
FY2022MISS
Actual:$14.9M
Est:$19.5M
FY2022MISS
$14.9M
FY2023BEAT
Actual:$9.9M
Est:$4.1M
FY2023BEAT
$9.9M

Analyst Estimates